CLINICAL_TRIALS trial_result · 2019-11-18

Clinical Trial Update: Clinical Study In Infants With Rapidly Progressive Lysosomal Acid Lipase Deficiency [Phase 2]

Phase 2 clinical trial in infants with rapidly progressive lysosomal acid lipase deficiency has been terminated; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Lysosomal Acid Lipase Deficiency | Phase 2 | Status: TERMINATED | Results posted: 2019-11-18